Sign In
Buy SIBN
$15.84
+0.630 (+4.14%)
At Close: Jun 18, 2026
SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026
04:09pm, Thursday, 04'th Jun 2026
SANTA CLARA, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bon
Bears are Losing Control Over Si-Bone (SIBN), Here's Why It's a 'Buy' Now
10:56am, Wednesday, 03'rd Jun 2026
Si-Bone (SIBN) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a tre
Wall Street Analysts Predict a 71.13% Upside in Si-Bone (SIBN): Here's What You Should Know
10:56am, Monday, 01'st Jun 2026
The average of price targets set by Wall Street analysts indicates a potential upside of 71.1% in Si-Bone (SIBN). While the effectiveness of this highly sought-after metric is questionable, the positi
Gazprom Neft says Q1 profit down 3.5% y/y
10:17am, Friday, 29'th May 2026
Gazprom Neft , the oil arm of Russia's energy giant Gazprom , said on Friday its first-quarter net profit declined by 3.5% year-on-year to 95.8 billion roubles ($1.35 billio
How Much Upside is Left in Si-Bone (SIBN)? Wall Street Analysts Think 65.27%
10:55am, Friday, 15'th May 2026
The consensus price target hints at a 65.3% upside potential for Si-Bone (SIBN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate
SI-BONE, Inc. (SIBN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
02:50pm, Tuesday, 12'th May 2026
SI-BONE, Inc. (SIBN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
SI-BONE, Inc. (SIBN) Q1 2026 Earnings Call Transcript
09:50am, Tuesday, 12'th May 2026
SI-BONE, Inc. (SIBN) Q1 2026 Earnings Call Transcript
SiBone Q1 Earnings Call Highlights
10:15pm, Monday, 11'th May 2026
SiBone NASDAQ: SIBN raised its full-year 2026 outlook after reporting double-digit revenue growth in the first quarter, with management pointing to new product launches, expanding physician adoption,
Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates
09:06pm, Monday, 11'th May 2026
Si-Bone (SIBN) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.15 per share a year ago.
SI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 Guidance
04:09pm, Monday, 11'th May 2026
Delivered ~11% worldwide revenue growth, record physician engagement and ~440% improvement in adjusted EBITDA Delivered ~11% worldwide revenue growth, record physician engagement and ~440% improvement
First Eagle Small Cap Opportunity Fund Q1 2026 Portfolio Review
01:23pm, Wednesday, 06'th May 2026
Leading contributors in the First Eagle Small Cap Opportunity Fund this quarter included Ultra Clean Holdings, Oil States International, Lincoln Educational Services, Advanced Energy and FormFactor. O
SI-BONE To Present at BofA Securities 2026 Healthcare Conference on May 12, 2026
04:09pm, Thursday, 30'th Apr 2026
SANTA CLARA, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bo
SI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026
04:09pm, Monday, 20'th Apr 2026
SANTA CLARA, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bo
SiBone (NASDAQ:SIBN) Shares Down 6.8% – What’s Next?
04:10am, Sunday, 12'th Apr 2026
SiBone (NASDAQ: SIBN - Get Free Report)'s share price was down 6.8% during trading on Friday. The company traded as low as $12.82 and last traded at $12.7650. Approximately 417,589 shares changed hand
SiBone $SIBN Stake Lowered by JPMorgan Chase & Co.
05:49am, Monday, 06'th Apr 2026
JPMorgan Chase and Co. decreased its stake in SiBone (NASDAQ: SIBN) by 32.1% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commi
